1/1

Export Ready

Ruxolitinib Rutinib Cream 1.5%

Name: Ruxolitinib Rutinib Cream 1.5%
SKU: 8495613
Price: 96.35 USD
Availability: InStock

Sold by BALAJI PHARMA · Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Price

₹ 96.35 /Unit

In stock

Inclusive of all taxes

Minimum order: 1 Unit

Export Snapshot

MOQ

1 Unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HSN Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for BALAJI PHARMA.

Suitable for

Importers · Distributors · Wholesalers

Bengaluru Dispatch on request Verified seller

BALAJI PHARMA

Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Registered address: Bengaluru, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Health Care Products.

View profile All products

Established

Not shared

Employees

–

GST

29AQTPJ8785C1Z2

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Aug 2019

Turnover

$250,000 - $1 MM

Incorporation Type

On request

Certifications & Awards

IMPORT EXPORT LICENSE ISSUED BY GOVERMENT OF INDIA GST ISSUED BY GOVERNMENT DRUG LICENSE ISSUED BY HEALTH AUTHORITY GOVERMENT

Product details

What are the specifications of this product?

Overview

Ruxolitinib Rutinib Cream 1.5% is a prescription topical treatment for skin conditions like eczema and vitiligo. By inhibiting JAK enzymes, it reduces inflammation and aids in skin repigmentation. Proper application as directed by a healthcare provider is essential for effectiveness and safety. This cream is produced following rigorous quality standards to ensure patient well-being.

Product Description

Ruxolitinib Rutinib Cream 1.5% is a topical medication used to treat certain skin conditions such as atopic dermatitis (eczema) and vitiligo. Ruxolitinib, the active ingredient, is a Janus kinase (JAK) inhibitor that works by modulating the immune response, thereby reducing inflammation and skin depigmentation. The cream is applied directly to the affected areas as prescribed by a healthcare professional. Patients should follow the application guidelines to achieve optimal results and minimize potential side effects. Manufactured under strict quality controls, Ruxolitinib Rutinib Cream ensures safety and effectiveness for dermatological use.

Description provided by BALAJI PHARMA.

Specifications

Concentration	1.5% Ruxolitinib
Type of Medication	Topical immunomodulator
Therapeutic Class	JAK inhibitor
Indicated Skin Conditions	Atopic dermatitis (eczema), Vitiligo
Formulation Type	Cream
Application Method	Topical application on affected skin
Storage Requirements	Store below 30°C, protect from light and moisture
Shelf Life	Typically 2 years from manufacture date
Regulatory Status	Prescription drug as per Indian medical guidelines
Manufacturer Quality Standards	Complies with CGMP (Current Good Manufacturing Practice)

Use cases

Category	Pharmaceuticals > Dermatology > Topical Medications
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Ruxolitinib Rutinib Cream 1.5%. Answers compiled from verified sellers' commercial terms and platform data.

Q: What skin conditions is Ruxolitinib Rutinib Cream 1.5% primarily prescribed for?

A: Ruxolitinib Rutinib Cream 1.5% is primarily prescribed for inflammatory skin conditions such as atopic dermatitis (eczema) and pigmentary disorders like vitiligo.

Q: How does Ruxolitinib Rutinib Cream 1.5% work on affected skin areas?

A: The cream works by inhibiting Janus kinase (JAK) enzymes involved in the immune and inflammatory pathways, reducing inflammation and promoting repigmentation by restoring skin pigment cells.

Q: Is Ruxolitinib Rutinib Cream 1.5% safe for long-term use?

A: Long-term use safety should be determined by a healthcare provider, as continuous inhibition of JAK enzymes requires medical supervision to minimize potential side effects.

Q: Can Ruxolitinib Rutinib Cream be applied to large skin areas?

A: Application should be limited to affected areas as prescribed by the healthcare professional; using the cream on large body surfaces should only be done under medical advice.

Q: What are the storage conditions for Ruxolitinib Rutinib Cream 1.5%?

A: The cream should be stored below 30°C, away from direct sunlight and moisture to maintain its stability and effectiveness.

Question not answered? Ask sellers directly — typical response within 4 hours.